The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy

Volume 11, Issue 1, December 2022 .

Source: OncoImmunology - September 17, 2022 Category: Cancer & Oncology Authors: Jiwei Huang Ruopeng Su Zeyu Chen Shuai Jiang Minfeng Chen Yichu Yuan Hailong Hu Changde Fu Zhiyang Huang Zhenyu Wang Bing Zheng Chancan Li Zaoyu Wang Yige Bao Ming Cai Jianming Guo Qiang Wei Wei Xue Source Type: research